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Using Caffeine Pills for Performance
Enhancement. An Experimental
Study on University Students’
Willingness and Their Intention to Try
Neuroenhancements
Ralf Brand* and Helen Koch
Sport and Exercise Psychology, University of Potsdam, Potsdam, Germany
Recent research has indicated that university students sometimes use caffeine pills for
neuroenhancement (NE; non-medical use of psychoactive substances or technology
to produce a subjective enhancement in psychological functioning and experience),
especially during exam preparation. In our factorial survey experiment, we manipulated
the evidence participants were given about the prevalence of NE amongst peers and
measured the resulting effects on the psychological predictors included in the Prototype-
Willingness Model of risk behavior. Two hundred and thirty-one university students were
randomized to a high prevalence condition (read faked research results overstating
usage of caffeine pills amongst peers by a factor of 5; 50%), low prevalence condition
(half the estimated prevalence; 5%) or control condition (no information about peer
prevalence). Structural equation modeling confirmed that our participants’ willingness
and intention to use caffeine pills in the next exam period could be explained by their
past use of neuroenhancers, attitude to NE and subjective norm about use of caffeine
pills whilst image of the typical user was a much less important factor. Provision of
inaccurate information about prevalence reduced the predictive power of attitude with
respect to willingness by 40-45%. This may be because receiving information about peer
prevalence which does not fit with their perception of the social norm causes people to
question their attitude. Prevalence information might exert a deterrent effect on NE via
the attitude-willingness association. We argue that research into NE and deterrence of
associated risk behaviors should be informed by psychological theory.
Keywords: attitude, prevalence information, prototype-willingness-model, social reactivity, doping
INTRODUCTION
Neuroenhancement (NE) is non-medical use of psychoactive substances or technology for the
purpose of producing a subjective enhancement in psychological functioning and experience
(Jongh et al., 2008; Mueller and Schumann, 2011; de Berker et al., 2013; Kipke, 2013; Clark and
Parasuraman, 2014; Farah et al., 2014; Maier and Schaub, 2015, for elements of this deﬁnition).
Sometimes the term ‘pharmacological cognitive enhancement’ is used to refer to the use of
psychoactive drugs to enhance psychological capacities such as attention, concentration, and
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memory (e.g., Franke and Lieb, 2010; Dietz et al., 2013). The
performance-enhancing eﬀects of drugs used as neuroenhancers
seem to be limited, regardless of whether they are prescription
drugs such as methylphenidate (Ritalin), mixed amphetamine
salts (Adderall) and modaﬁnil (Provigil); illicit drugs (e.g.,
amphetamine, cocaine, ecstasy) or over-the-counter products
(e.g., caﬀeinated drinks, energy drinks, Ginkgo biloba; e.g.,
Franke et al., 2014). Given the considerable overlap between
the inconsistent cognitive eﬀects of most of these substances on
cognitive capacity and their incidental mood- and motivation-
related eﬀects (e.g., Ilieva et al., 2013) describing them as
‘cognitive enhancers’ may be overly narrow and restrictive
(Zohny, 2015).
Wolﬀ and Brand (2013) pointed out that information about
the type and eﬀects of a substance does not explain why people
do or do not experiment with neuroenhancers. They argued
that motivation to experiment with neuroenhancers could be
explained by expectations about their eﬀects. Someone drinking
a strong cup of coﬀee explicitly in order to stay awake and thus
study for longer or to enhance speciﬁc cognitive capacities (e.g.,
attention, recall memory) thus provides an adequate example of
attempted NE. In this article, we will treat NE as goal-directed
behavior intended to produce an improvement in academic
performance.
There is an active debate about the ethics and pros and cons
of NE at present and in the future (e.g., Hildt and Franke,
2013). Scientists remind us not to overestimate the eﬀects of
substances used as neuroenhancers (e.g., Franke et al., 2014;
Zohny, 2015), but the market for substances (e.g., soft-drinks)
promising an energy boost, or cognitive beneﬁts as well as mood
enhancement (Ishak et al., 2012) is increasing. In the light of
these developments it is especially important to avoid fuelling the
media hype surrounding NE (Partridge et al., 2011) and to state
clearly the aims and limitations of published research. This paper
is on the psychology of NE. We intend to describe and analyze
university students’ motivation to experiment with NE in terms
of a social cognitive theory of behavior.
Prevalence of NE in Academia
There is limited reliable evidence on prevalence of NE in
academia. Extant studies diﬀer with regard to underlying
deﬁnitions (e.g., whether NE is restricted to use of prescription
drugs), representativeness of the sample (ad hoc; random), the
types of substance considered (over-the-counter preparations;
prescription drugs; illegal substances), data collection method
(e.g., extent to which the conﬁdentiality of self-reports is
guaranteed) and time period investigated (e.g., point vs. life-
time prevalence; Franke et al., 2014). Based on self-report
questionnaires administered to large samples it has been reported
that 5% in the year 2010/2011 (Middendorﬀ et al., 2012) and 6%
in 2014/2015 (Middendorﬀ et al., 2015) of German university
students abuse prescription drugs or illicit substances for “brain
doping” during their years of study. Estimates of prevalence
based on randomized response techniques that help to ensure
the conﬁdentiality of responses vary from 4% (Middendorﬀ
et al., 2015) to as much as 20% for 1-year prevalence in a
study including caﬀeine pills as a neuroenhancer (Dietz et al.,
2013). This latter ﬁgure is very similar to the reported abuse
of prescription drugs for NE by research professionals (Maher,
2008). Maher reported that 20% of Nature readers from 60
nations who responded to an informal survey confessed to
having used a prescription drug for NE at least once; however,
Wiegel et al. (2015) reported that the lifetime prevalence of self-
reported NE in a large sample of German university teachers and
professors was only 1%.
This study focused on university students’ use of caﬀeine pills
for NE. To date there has been only one pilot study of university
students’ use of coﬀee, caﬀeinated drinks, and caﬀeine pills in
Germany (Franke et al., 2011). The authors concluded that 10.5%
of university students had used over-the-counter caﬀeine pills as
neuroenhancers on at least one occasion.
Psychological Factors Explaining NE in
Students
Several studies have analyzed students’ motivation for NE.
Eickenhorst et al. (2012) investigatedGerman university students’
motives for using prescription drugs and illegal substances as
neuroenhancers. The main motives reported by their participants
were a desire to enhance concentration and alertness or to
increase cognitive functioning in general; to enable them to
relax, cope with stress and withstand performance pressure
and a fear of being disadvantaged if they did not use such
substances. Middendorﬀ et al. (2012, 2015) reported that when
interviewed most students indicated that their main motive for
NE was to maintain, rather than enhance performance and that
use of prescription drugs and over-the-counter products was
particularly frequent during exam preparations.
Some authors have tried to go beyond descriptions of users’
motives and elucidate the psychological processes underlying
NE behavior. Wolﬀ and Brand (2013) regressed students’
NE behavior (use of prescription drugs and over-the-counter
products) on their underlying positive attitude to NE and
Sattler and Wiegel (2013) reported that six-month prevalence
of prescription drug NE was higher in students with high test
anxiety.
Three studies investigated the inﬂuence of selected
psychological factors on participants’ decisions about
trying NE using online factorial questionnaires (pseudo-
experimental designs; see “Materials and Methods” section in
this article). Sattler et al. (2013b) explored university students’
and teachers’ rationales for use of neuroenhancers using a
hypothetical scenario in which they systematically varied several
variables (indicated in italics): “A university [teacher/student]
considers trying to enhance his cognitive performance for his
[work/studies] by using a prescription drug which he does not
require on medical grounds. He would be able to get the pills
for free. A study that found that there is a 60 percent chance
that the drug will improve cognitive performance by 250 percent
caught his attention. The side eﬀects were investigated: using the
medication causes slight headaches in one out of 100,000 users.
Possible additional side eﬀects are unknown.” Participants were
asked to rate how willing they would be to use the substance
described for NE if they were in the position of the person in
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the scenario. The authors controlled for several factors which
they thought might inﬂuence decisions (e.g., moral evaluation
of NE, conceptualized as the participant’s internal norm). The
authors, e.g., found that the probability and severity of side-
eﬀects were negatively associated with willingness to use NE;
internalization of social norms against use of neuroenhancers was
also negatively associated with willingness to use NE. Sattler et al.
(2013a) reported that NE was subject to a contagion eﬀect: peer
pressure (apparently high prevalence of substance use amongst
peers) increased participants’ willingness to use NE whereas
formal prohibition and provision of information about health
side-eﬀects decreased willingness. Sattler et al. (2014) investigated
drivers of and obstacles to drug use in university students from
the perspective of economic decision theory, assuming that
decisions about NE would be based on a rational evaluation of
the probability that a substance would help users attain their
goals. Two thirds of their participants staunchly refused to use
a prescription drug for NE, a similar proportion to that found
in the two previous studies (Sattler et al., 2013a,b). Low intrinsic
motivation, high test anxiety and previous use of drugs for
NE were associated with greater willingness to use NE in the
future. As in earlier studies willingness to use neuroenhancers
was negatively associated with high internalization of social
norms against NE (i.e., moral disapproval of NE; see above) and
positively associated with apparent peer prevalence.
Call for Theory-Driven Analysis of NE
Behavior
Neuroenhancement is a multifaceted phenomenon (e.g., goals;
factors governing decisions about use) that requires explanation
at several levels (e.g., personal; social; environmental) based on
a sound understanding of underlying psychosocial processes
(e.g., evaluation of peer behavior). To date, however, most
psychological research has been limited to identifying variables
correlated with use of neuroenhancers and appears not to have
been informed by psychological theory. Theory is an essential
element of behavioral research; in particular the development
of eﬀective interventions is underpinned by explanatory models
of behavior (Fishbein and Cappella, 2006). Experimental testing
of theoretically derived hypotheses is superior to theoretically
less-informed approaches, because it minimizes the risk of
encountering arbitrary eﬀects and overestimating the inﬂuence
of variables (e.g., because of variable and case sampling errors).
This study aimed to address this research gap. It was based
on the empirical ﬁndings from earlier psychological studies, but
used an established theory of behavior to derive a model of the
psychological determinants of NE behavior (cf. Zelli et al., 2015).
Two other studies have used psychological theory to inform
analyses of NE behavior. Wolﬀ et al. (2014) used Job Demands
Resources Theory to show that use of NE had a negative impact
on university students’ psychological perceptions of academic
demands and interfered with their intrinsic motivation and
Wolﬀ et al. (2013) used the strength model of self-control to
predict ﬁrst use of NE. This study tested predictions derived
from the Prototype Willingness Model (PWM; Gibbons et al.,
1998). We investigated how information about peer behavior
inﬂuenced associations between the psychological variables
predicting university students’ willingness and intention to use
caﬀeine pills to enhance cognitive performance.
The Prototype-Willingness Model
At the core of the PWM (Gibbons et al., 1998) is the idea
that sometimes persons will ﬁnd themselves in situations which
facilitate but do not compel particular behaviors. The model
postulates that under such circumstance behavior is determined
by the individual’s willingness to perform the behavior in
question rather than by a process of reﬂection with resulting
plans and an intention at its end. Gibbons et al. (1998) deﬁned
willingness as an individual’s openness to risk opportunity, i.e.,
to perform a risky behavior in the absence of a speciﬁc plan or
intention to do so. Although willingness may be accompanied
by a congruent intention this is not necessarily the case.
According to the PWM willingness is a foundation from which
overt behavior can emerge spontaneously and it can, at least
temporarily, sustain that behavior (Gerrard et al., 2008).
The PWM is rooted in empirical analyses of adolescent risk-
taking behavior and developmental health psychology theory.
The model suggests two pathways for behavioral regulation,
the reasoned pathway, which culminates in an intention and
the social reactive pathway, from which a degree of willingness
emerges. The two pathways are connected in various ways, most
importantly through a postulated predictive relationship between
willingness and intention (but not vice versa). The PWM is
illustrated in full in Figure 1.
The PWM assumes that future behavior is informed by past
behavior. The variable ‘past behavior’ is a factor in all processes
or steps of both the reasoned and social reactive pathways, which
respectively, inﬂuence ‘willingness’ and ‘intention’ to perform a
given behavior (Gibbons et al., 2009).
All variables in the reasoned pathway are drawn from the
Theory of Reasoned Action (Fishbein and Ajzen, 1975, 2010)
which treats ‘attitude’ as the sum of evaluations of a psychological
object captured by evaluations of attribute dimensions such as
good-bad, harmful-beneﬁcial, pleasant-unpleasant and likeable-
dislikable (Ajzen, 2006). Another variable involved in the
reasoned pathway is ‘subjective norm,’ which is deﬁned as the
perceived social pressure to engage or not engage in a given
behavior. The PWM refers to descriptive norms (Gibbons et al.,
1998). Items used to assess subjective norms should therefore
capture individuals’ perceptions of what signiﬁcant others do
(e.g., “Do you think your peers would use caﬀeine pills to enhance
cognitive performance?”) rather than what signiﬁcant others
think the respondent should do (injunctive norm; e.g., “Do you
think that your peers would accept you taking caﬀeine pills for
cognitive enhancement?”). ‘Intention,’ which is the PWM’s most
proximal predictor of behavior of the reasoned pathway, is based
on a combination of attitude and descriptive norm.
The social reactive pathway is deﬁned by certain variables’
relationships with willingness. ‘User prototype’ is one of these
variables. Gerrard et al. (2008) recommended that this variable
should be measured using items such as “Take a moment to think
about what kind of student in your age group uses caﬀeine pills to
enhance cognitive functioning. We are not interested in anyone
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FIGURE 1 | Raw data and boxplots for participants’ answers to the question in manipulation check 1 (“According to recent research what
percentage of university students in Germany have used caffeine pills at least once to enhance their performance and improve their learning?”) in
experimental conditions A (50% peer prevalence), B (5%), and C (no information on peer prevalence).
in particular, just the typical person of your age who could do this.
How [popular/smart/selﬁsh] is this person?” In the context of the
PWM a ‘user prototype’ is thus the sum of the characteristics
of an imagined peer who engages in the target behavior (e.g.,
the ‘typical’ smoker). The social acceptability of a user prototype
is positively associated with willingness to engage in the target
behavior. ‘Subjective norms’ inﬂuence behavior via the reasoned
pathway (through their association with ‘intentions’) and via the
social reactive pathway, where they are postulated to be associated
with ‘willingness.’ The socially reactive nature of the willingness
construct is underscored by Gerrard et al.’s (2008) recommended
items for measuring it, e.g., “Suppose you were studying with
a group of friends and there were caﬀeine pills available. How
willing would you be to take one?”
In the past few years, research on the PWM has accumulated
in health psychology and a meta-analysis was published very
recently (Todd et al., 2014). One of the conclusions from this
meta-analysis was that the predictive power of the relationships
postulated by the PWM is only marginally better in adolescent
samples (R2 = 0.33) than in adult samples (R2 = 0.29), suggesting
that although the model was developed to predict risk-taking
behavior in adolescents it may be just as useful for predicting
adult behavior. It is important to note that the meta-analysis did
not test the full set of relationships involving PWM variables;
it focused on the postulated correlations between prototypes,
willingness and intentions and thus corroborated the postulated
processes of the social reactive path. Most importantly the
meta-analysis revealed that although willingness and intention
are sometimes highly correlated they also act as independent
predictors of risk behavior. Willingness explained an additional
4.9% of variance in behavior after intentions had been taken into
account (Todd et al., 2014). The postulated correlations between
variables in the reasoned pathway have been tested in several
other PWM-related studies (e.g., the association between past
behavior and attitude, Gibbons et al., 1998; pairwise associations
between norms and intentions and willingness, Gerrard et al.,
2008) and in meta-analyses which have conﬁrmed the pattern
of relationships among attitude, norms, intentions, and behavior
(Armitage and Conner, 2001) postulated in the Theory of
Planned Behavior (Ajzen, 1991).
Astonishingly, however, there is a dearth of empirical analyses
of the full set of PWM variables using, e.g., multivariate model
testing methodology.
This Study
Neuroenhancement research (e.g., Wolﬀ and Brand, 2013; Schelle
et al., 2014), research in related domains (e.g., doping in
sport, Ntoumanis et al., 2014) and behavior change research
more generally (e.g., McEachan et al., 2011) have shown that
variables used in social cognitive theories, especially attitude,
perceived social norms, and intentions (e.g., Fishbein and
Ajzen, 1975, 2010), are important psychological predictors
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of behavior. Recently university students’ willingness to use
psychoactive substances for performance enhancement emerged
as an empirically useful dependent variable in NE research (e.g.,
Sattler et al., 2013b). The PWM is a comprehensive psychological
theory of behavior that integrates all these variables. The PWM
postulates two interacting pathways of behavioral regulation:
the reasoned action path, in which attitudes and norms predict
intention (the most proximal predictor of behavior) and the social
reactive path, which integrates information from prototypes,
attitudes, and norms to form another proximal predictor of
behavior, i.e., behavioral willingness. The PWM thus represents
an integrative psychological framework for the study of NE
behavior.
Earlier research indicated that 10% of German university
students use caﬀeine-containing products with the purpose to
enhance cognitive performance on at least one occasion during
their student life (Franke et al., 2011). Use of drugs for NE carries
health risks (Schermer et al., 2009) and students consider it a risky
behavior (Sattler et al., 2014). Peer behavior and peer pressure
have been shown to be factors in university students’ decisions
about use of enhancers (Sattler et al., 2013a).
In our investigation, we sought to manipulate groups of
university students into believing either that use of caﬀeine
pills for NE was rather widespread amongst their peer group
(experimental condition A: prevalence given as 50%; i.e., ﬁve
times more than the actual estimated prevalence) or rare
(condition B: prevalence given as 5%; i.e., half the estimated
prevalence). A third group received no information about
prevalence and served as a control group (condition C).
We investigated use of caﬀeine pills speciﬁcally. Caﬀeine is
available in over-the-counter products and in higher doses as a
prescription drug. We deliberately restricted our investigation
to use of caﬀeine in pill form, because we assumed that such
products were more likely to be seen as ‘pharmaceuticals’ than,
for example, caﬀeinated energy drinks which might be perceived
as an everyday consumable.
First of all, we tested whether the PWM could be used to
describe university students’ willingness and intentions with
respect to use of NE. Our second research question was based on
the assumption that university students would have some sort of
subjective perception of the prevalence of NE in their peer group
and that this perception would shape their thinking about NE.
We explored whether experimentally manipulating information
about the prevalence of use of caﬀeine pills for NE amongst peers
(high prevalence; low prevalence; no prevalence information)
would inﬂuence the behavioral determinants speciﬁed in the
PWM (attitude, subjective norm, user prototype, willingness,
and intention) and the associations between these variables and
willingness or intention to engage in the target behavior.
MATERIALS AND METHODS
This study was conducted online as a factorial survey experiment
(Jasso, 2006). This method enables the researcher to determine
the inﬂuence of experimentally manipulated information on
respondents’ self-reported thoughts, feelings, and decisions. The
Questback EFS 10.6 software was used to run the experiment.
The questionnaire was presented in German (i.e., all example
items below are English translations from the German originals).
The access link was distributed via Facebook and email thus
creating a convenience sample drawn from the target population,
university students in Germany. Data collection started in March
2015 and ended 3 weeks later in April 2015. The study was
carried out in accordance with the recommendations of the
ethical committee of the University of Potsdam (February 2015).
All participants gave written, informed consent in accordance
with the Declaration of Helsinki.
Participants
Four hundred and thirty-six university students clicked on
the link giving access to our survey. Of these 386 (88.5%)
went beyond the title page and 305 (69.9%) completed the
questionnaire. Forty-nine students did not consent to having
their data saved and analyzed on the last page, so the responses
of 256 participants (58.7% of those who clicked on the link)
were stored for analysis. Twenty-ﬁve participants had provided
incomplete data (>40% missing responses) and were therefore
excluded from the ﬁnal analyses, so the ﬁnal sample consisted
of data from 231 German-speaking university students of whom
75.8% were women (M age = 23.5 years ± 2.7; range: 18–
35 years) and 23.8% were men (M age = 25.4 years ± 3.8;
range: 20–40 years). One 24-year-old participant did not provide
information about gender.
Experimental Manipulation
When they clicked through to the second page of the online
questionnaire participants were randomly assigned to one of
the three experimental conditions. Participants in condition A
(ﬁvefold overestimation of prevalence; Franke et al., 2011) read
the following, “A few months ago a representative study showed
that more than 50% of all university students in Germany
use caﬀeine pills in order to enhance cognitive functioning
and improve learning.” Participants in condition B (i.e., 50%
underestimation of prevalence) read that only 5% of students
used caﬀeine pills for NE. Participants in condition C read, “A few
months ago a representative study showed that some university
students in Germany use caﬀeine pills to enhance cognitive
functioning and improve learning.”
Measures and Information
Past Behavior
This indicator was intended to capture participants’ historical
NE behavior. They were asked four yes-no questions: “Have you
ever used caﬀeine pills to enhance your cognitive performance
and improve your learning?,” “Have you ever used a caﬀeinated
synthetic drink (‘energy drink’) to enhance your cognitive
performance and improve your learning?,” “Have you ever
used any other synthetic substance to enhance your cognitive
performance and improve your learning?,” and “Have you ever
drunk a cup of strong coﬀee or tea to enhance your cognitive
performance and improve your learning?” Responses to these
four questions were analyzed separately to characterize the
sample, but the mean score was used in the main statistical
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analyses. McDonald’s ωh = 0.52 that takes into account the
dichotomous nature of these heterogeneous set of items indicated
adequate general factor saturation.
Subjective Norm
The descriptive facet of this PWM variable was captured using
three statements (see Hammer and Vogel, 2013) to which
participants responded using a six-point, i.e., forced choice
Likert-type scale (1 = “totally disagree” to 6 = “totally agree”):
“Peers whose opinions I value use caﬀeine pills to enhance their
cognitive performance and improve their learning,” “People who
are important to me would use caﬀeine pills to enhance their
cognitive performance and learning if they were in my position,”
and “People around me have used caﬀeine pills to enhance their
cognitive performance and improve their learning.” The mean
score for all three statements was used in the statistical analyses.
In our sample the internal consistency of this scale was α= 0.81.
Attitude
Participants used a seven-point scale to rate use of caﬀeine pills
to enhance cognitive performance and improve learning on ﬁve
semantic diﬀerentials: ‘bad–good,’ ‘unhealthy–healthy,’ ‘right–
wrong,’ ‘risky–safe,’ and ‘useless–useful’ (see Ajzen, 2006). Higher
values represented a more positive attitude toward use of caﬀeine
pills for NE. The mean score from these ﬁve items was used for
statistical analyses. In our sample the internal consistency of the
scale was α = 0.80.
User Prototype
Participants were asked to imagine what a typical user of caﬀeine
pills – perhaps a fellow student from their university – might
be like (see Gibbons et al., 1998) and use a seven-point scale
to describe that person in terms of ﬁve semantic diﬀerentials
‘stupid–smart,’ ‘unpopular–well-liked,’ ‘motivated–unmotivated,’
‘eﬀective–ineﬀective,’ and ‘wrong–right.’ The mean score for the
scale was used in statistical analyses; higher means indicated
greater social acceptability. In our sample the internal consistency
of the scale was α= 0.75.
Willingness
Participants were asked to read two hypothetical scenarios and
rate their willingness to use NE in each (see Gibbons et al., 1998).
In scenario one, they read: “Suppose that a friend from your study
program has written on Facebook that he recently used caﬀeine
pills from the drugstore to improve his learning.” Participants
then rated how likely it was that they would take caﬀeine pills
at some point using a six-point, i.e., forced choice Likert-type
scale (1 = “very unlikely” to 6 = “very likely”). In scenario two,
they read: “Usually you are well prepared for exams, but this time
you feel tired and worn out. Although you are trying hard, you
just don’t seem able to prepare well for the forthcoming exam.
You have the option of taking caﬀeine pills to dispel your fatigue
and thus revise more eﬀectively.” Participants then responded to
two questions (“If you had the opportunity, would you be willing
to use caﬀeine pills?” and “Would you be willing to experiment
with caﬀeine pills under some other circumstance if you had
the opportunity to do so?”) using a six-point, i.e., forced choice
Likert-type scale (1 = “absolutely not willing” to 6 = “perfectly
willing.” A mean score was calculated and used for statistical
analyses, with higher scores indicating greater willingness to use
caﬀeine. In our sample the internal consistency of this scale was
α= 0.88.
Intention
This variable was measured very simply, by asking participants
the single speciﬁc question “Do you intend to use caﬀeine pills for
cognitive enhancement and to improve learning in preparation
for your next exams?” Responses were given on a six-point, i.e.,
forced choice Likert-type scale (1 = “deﬁnitely not” to 6 = “yes,
deﬁnitely”).
Personal Details
Participants were asked to provide their age and gender, and state
whether they were currently enrolled as a university student.
Manipulation Checks
After responding to all the scales described above and providing
personal data participants were asked “According to recent
research what percentage of university students in Germany have
used caﬀeine pills at least once to enhance their performance
and improve their learning?” The response was entered in a
free-text input ﬁeld. Participants were also asked whether they
thought there was anything suspicious, wrong, or strange about
the questionnaire, and in particular if they thought they had
been manipulated by the ways in which we gave or asked for
information earlier in the questionnaire.
Debriefing
The last page of the questionnaire provided full information
about the goals and procedure for the study. This included a
statement of the actual estimated prevalence of use of caﬀeine
pills for NE among university students (i.e., 10%) and an explicit
admission that we had tried to deceive our participants about this
statistic in two experimental conditions. Participants had to tick
response boxes to indicate that they had read and understood
this information and consented to the conﬁdential storage and
analysis of their data for scientiﬁc use by the Division of Sport
and Exercise Psychology of the University of Potsdam.
Statistical Analyses
SPSS 22.0 was used to calculate all descriptive statistics and for
tests for group diﬀerences (ANOVA, MANOVA) and frequency
distribution tests (χ2 test). Structural equation modeling (SEM)
with Amos 22.0 was used to determine whether our data were
consistent with the PWM. General model ﬁt was evaluated
according to established criteria (RMSEA < 0.08, CFI ≥ 0.95,
SRMR < 0.08; e.g., Hu and Bentler, 1999; Beauducel and
Wittmann, 2005) and a Bollen–Stine bootstrap (1000 iterations)
was used to estimate conﬁdence intervals for regression weights.
A SEM multigroup moderation approach (Byrne, 2010) was
used to investigate experimentally induced alterations in the
relative predictive power of PWM predictors of willingness and
intention (Lowry and Gaskin, 2014). These tests were carried
out with a program created by Gaskin (2012) which calculates
z-scores based on critical ratio tests of the multigroup model and
unstandardized estimates.
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The signiﬁcance level was set at p < 0.05 for all analyses.




One-way ANOVA revealed no signiﬁcant age diﬀerences between
the three groups [F(2) < 1], indicating that in this respect the
randomization procedure was successful. However, assessment
of the gender ratios in the three groups indicated that there
were fewer men (n = 12) and more women (n = 73) than
expected in experimental condition B, χ2(2) = 7.82, p < 0.05.
Previous research suggests that male and female students may
diﬀer in their use of caﬀeine for NE (Franke et al., 2011), so
this randomization error might have resulted in group diﬀerences
in ‘past behavior’; however, in practice there were no signiﬁcant
diﬀerences between conditions with regard to either historical
use of speciﬁc substances (all ps n.s.; see below) or mean scores
used in the statistical analyses (MANOVA results; see below).
We therefore concluded that in spite of the randomization error
(under-representation of men in condition B) the randomization
process was successful overall.
Manipulation Check
The groupmean responses to the question about what percentage
of university students in Germany used caﬀeine pills for NE
on at least one occasion were as follows: group A (ﬁvefold
overestimate of prevalence, i.e., 50%)M = 50.39% (SD = 13.24),
group B (50% underestimate of prevalence, i.e., 5%)M = 11.28%
(SD = 13.88) and group C (no information about prevalence)
M = 38.18% (SD = 20.34). This ﬁnding is illustrated in Figure 1.
There were group diﬀerences in responses [univariate ANOVA,
F(2,228) = 130.2, p < 0.01]. The participants’ free responses
to the second manipulation check question indicated that
participants did not see through the experimental manipulation.
Description of Past Behavior
Thirty-one participants (13.4%) reported having used caﬀeine
pills to enhance their performance on at least one occasion. High-
dose synthetic caﬀeinated drinks (’energy drinks’) had been used
by 39.0% (n= 90) and 14.3% (n= 33) reported having used some
other synthetic substance for NE, whilst 77.1% (n= 178) had used




Descriptive statistics for all variables are summarized in Table 1.
The value of Mardia’s multivariate kurtosis statistic was 1.24,
indicating the multivariate normality of our data. The low
variance inﬂation factor of 1.7 suggested that multicollinearity
could be dismissed as a possible source of bias.
Structural equation modeling indicated that our data were a
good ﬁt with the predictions of the PWM after we had taken into
TABLE 1 | Descriptive statistics for all variables included in SEM.
Variables M (SD) Range Skewness Kurtosis
Past behavior 1.36 (0.26) 1–2 0.68 0.12
Attitude 2.88 (1.04) 1–5.80 0.06 −0.23
Subjective norm 2.25 (1.19) 1–6 0.79 −0.47
User prototype 4.34 (0.90) 1–7 −0.09 0.40
Intention 2.13 (1.38) 1–6 1.04 0.08
Willingness 3.00 (1.39) 1–6 0.21 −1.08
N = 231 for all variables.
account additional correlations between ‘past behavior’ and the
residual variance in ‘intention’ (r = 0.18, p < 0.05) and between
‘past behavior’ and the residual variance in ‘willingness’ (r = 0.30,
p < 0.01), χ2(1) = 1.95, p = 0.16; RMSEA = 0.06; CFI = 0.99,
SRMR = 0.01. The structural model with regression weights for
relationships between variables (bootstrapped CIs inTable 2) and
determination coeﬃcients for variables is displayed in Figure 2A.
Regression weights for the association between ‘attitude’ and
‘intention’ in the reasoned action pathway and the sequence
of associations linking ‘past behavior’ to ‘user prototype’ to
‘willingness’ in the social reaction path were all low (all
βstand. ≤ 0.10). ‘Willingness’ had a substantial eﬀect on ‘intention’
(βstand. = 0.62). The model explained 38% of variance in
‘willingness’ and 61% of variance in ‘intention.’
In summary, our main hypothesis, that the PWM can be
applied to university students’ willingness and intentions with
respect to use of caﬀeine pills for NE, was supported.
Experimental Effects on Variable Means
The MANOVA omnibus test revealed no signiﬁcant eﬀect
of experimental condition on the six PWM variables,
F(12,448) = 0.91, n.s. We therefore concluded that provision of
experimentally manipulated information about peer behavior did
not produce group mean diﬀerences in any of the investigated
variables.
Experimental Effects on Regression Paths
Model ﬁt indices remained acceptable for the multigroup
estimation model, χ2(3) = 6.85, p = 0.08; RMSEA = 0.07;
CFI = 0.99, SRMR = 0.01. Provision of experimentally
manipulated evidence about prevalence lowered regression
TABLE 2 | Bootstrapped 95% CIs for regression weight (βstand.).
Parameters Lower boundary Upper boundary
Past behavior → Subjective norm 0.37 0.58
Past behavior → User prototype −0.08 0.19
Past behavior → Attitude 0.34 0.53
Subjective norm → Willingness 0.08 0.30
Attitude → Willingness 0.28 0.50
User prototype → Willingness −0.06 0.14
Subjective norm → Intention 0.01 0.24
Attitude → Intention −0.01 0.21
Willingness → Intention 0.51 0.72
N = 231 for all variables.
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FIGURE 2 | The Prototype Willingness Model (Gibbons et al., 2009) with results from SEM in (A) (R2 for PWM variables and βstand. for paths) and the
illustration of experimental effects (B).
weight for the associations between ‘attitude’ and ‘willingness’
in condition A by 45% relative to the control group, which did
not receive any prevalence information; a similar eﬀect (lowered
regression weight by 40%) appeared as a statistical trend in
condition B (Figure 2B; condition A: βstand. = 0.31, p < 0.01;
condition B: βstand. = 0.34, p < 0.01; condition C: βstand. = 0.57,
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p< 0.01). Thismeans that in our sample provision of information
about prevalence of use of caﬀeine pills for NE decreased the
predictive value of attitude to use of caﬀeine for NE onwillingness
to do so.
DISCUSSION
Testing predictions derived from a theory of behavior minimizes
the risk of reporting random eﬀects and overestimating
relationships; it is thus a suitable strategy for uncovering the
psychological mechanisms underlying behavior and behavior
change (Zelli et al., 2015). This study showed that the PWM,
an established social cognitive theory of behavior, can be used
to describe university students’ willingness and intention to use
caﬀeine pills to enhance their academic performance (NE). On
the basis of this result and previous ﬁndings on the eﬀects of
peer pressure (Sattler et al., 2013a,b, 2014) we explored whether
providing information about the prevalence of a behavior
amongst peers – in this case use of caﬀeine pills for NE – would
inﬂuence motivational variables and their interrelationships. We
found that attitude was a less powerful predictor of willingness
to use caﬀeine pills in experimental condition A, in which
participants were informed that recent research indicated that
50% of all university students in Germany used caﬀeine for NE.
There was a trend in the same direction (p < 0.10) in condition
B, where participants were informed that only 5% of peers used
caﬀeine for NE.
Interestingly, in this investigation attitude was a much
weaker predictor of intention than in other investigations
of problematic consumption behavior (e.g., r+ = 0.62 in a
meta-analysis of intention to consume alcohol, Cooke et al.,
2014; r = 0.55 in a meta-analysis of athletes’ intention to
use doping substances, Ntoumanis et al., 2014). The most
likely explanation for this is that we chose to measure a very
speciﬁc intention, i.e., intention to use caﬀeine, in pill form,
in the next exam period. The relatively skewed distribution
(z = 1.04) of rather low intentions (M = 2.13 ± 1.38 on
a six-point Likert scale) corroborates this explanation. Our
participants’ willingness to use caﬀeine for NE was somewhat
higher (M = 3.00 ± 1.39) and barely skewed (z = 0.21).
We consider that our very straightforward way of measuring
a very speciﬁc intention represents a valid, reliable indication
of intention with respect to the behavior in question, we
therefore argue that the ‘willingness’ construct is the more
interesting proximal psychological predictor of NE (Sattler et al.,
2014) and should be investigated further. In particular, we
recommend research into the conceptual relationship between
willingness and intention (empirical data from many studies
based on the PWM suggest that the two constructs are
fairly highly correlated, c.f. Todd et al., 2014; βstand. = 0.62
in our sample). We think that willingness to engage in a
given behavior may be much more sensitive to changes in
motivational predictors (e.g., in attitude) and to situational
factors than an intention to do so. A fundamental assumption
of the PWM is that willingness is the basis of socially
reactive, i.e., ‘spontaneous’ or unplanned behavior; this suggests
that willingness would be a suitable target for public health
interventions.
Structural equation modeling modeling enabled us to estimate
correlations between the PWM variable past behavior and the
residual variance in willingness and intention with respect to
the relevant behavior. In accordance with Wolﬀ and Brand’s
(2013) behavioral approach to investigating motivation to use NE
we measured our participants’ past NE behavior without regard
for the substances involved although we measured willingness
and intention in relation to a speciﬁc substance, namely caﬀeine
pills. Our data suggests that an individual’s general disposition
to use neuroenhancers is a product of unobserved variables in
addition to the PWM variables we measured. These unidentiﬁed
variables have a considerable impact on willingness and intention
to use speciﬁc neuroenhancers and perhaps NE more generally.
Candidates for these thus far unidentiﬁed variables might be
found in the psychological roots of NE behavior and perhaps in
the goals at which NE is directed. More generally we endorse
Lazuras’s (2015) recommendation, made in relation to research
on doping in sport (see Zelli et al., 2015, for parallels between
doping and NE), that researchers should develop coherent
explanatory models that account for environmental inﬂuences,
demographic variables, culture, and exposure to information in
the media.
The PWM variable past behavior was linked to social norm
and attitude but had almost no relationship with user prototype.
Participants’ images of the “typical user” (Gibbons et al., 2009) of
caﬀeine pills, including social acceptability (i.e., user prototype)
also had little impact on willingness to use NE. In the terminology
of the PWM the basis for socially reactive use of caﬀeine
pills to improve academic performance seems to be the strong
inﬂuence of attitude on willingness; user prototype appears
to play little role in socially reactive NE in this instance.
This may be due to our choice of example neuroenhancer,
namely caﬀeine pills. Caﬀeine pills may be more likely than
other caﬀeine products such as ‘energy drinks’ to be treated
as a pharmaceutical that should not be taken recklessly, or
in response to peer pressure. If we assume that university
students are better educated than the general population we
might expect them to be more resistant to social inﬂuences
and generally less prone to unplanned, socially reactive behavior
and hence that user prototype would be a stronger predictor
of NE behavior in other samples and in relation to other
substances.
The experimental manipulation of information about
prevalence of use of caﬀeine for NE amongst peers (rather
widespread; rare) did not aﬀect participants’ subjective norm
for this behavior, in other words quantitative information about
prevalence did not appear to be internalized and incorporated
into belief systems immediately. This may be because the
information given in conditions A (50% prevalence, i.e., a
ﬁvefold overstatement of actual estimated prevalence) and B
(5%, i.e., half the estimated prevalence) did not correspond
with our participants’ existing perceptions based on personal
observations. The responses of the university students in
condition C (no information on peer prevalence) to the
manipulation check question about prevalence (see Figure 1)
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provide some indication of students’ pre-existing perceptions of
NE prevalence and suggest that such perceptions vary widely.
We suggest that receiving new information about peer prevalence
might weaken the association between attitude to a given
behavior and willingness to engage in it. Our ﬁnding that in
condition A the predictive power of attitude with respect to
willingness decreased by 45% might be taken as an indication
that our participants had begun to reﬂect on their point of view in
response to the rather surprising – i.e., inaccurate, experimentally
manipulated – information about the prevalence of NE amongst
their peer group. This ﬁnding reinforces our main contention,
shared by other authors (Wolﬀ and Brand, 2013; Wolﬀ et al.,
2014; Zelli et al., 2015), which is that social cognitive theories
which deﬁne relationships between, e.g., attitude and other
psychological predictors of behavior (in this case NE) provide
valuable insight into the psychological mechanisms underlying
behavior change and hence can be used to develop behavior
prevention programs.
The limitations of this research should be acknowledged. First
of all, psychological theories such as the PWM are intended
to predict behavior. We have neither predicted a temporal
relationship (e.g., that past behavior inﬂuences attitude) nor
measured observed behavior (e.g., use of caﬀeine pills in the
next exam period) following an experimental treatment. We
experimentally manipulated one variable (information about
prevalence) and were thus able to make causal inferences
related to this manipulation (providing information about
prevalence reduced the inﬂuence of attitude to NE on
willingness to engage in it). We are, however, unable to
draw conclusions about the validity of theoretical assumptions
about the causal relationships between other variables (e.g.,
the direction of the association between subjective norms and
willingness; Figure 1) as our evidence on this was correlational.
Longitudinal studies are needed to draw conclusions about
the consequences of changes in motivational determinants.
Another limitation of our study is that our analyses were
based on data from an ad hoc sample of university students
which may not have been representative of the population.
Although, we are optimistic that our ﬁndings are valid
further studies are needed to corroborate our ﬁndings and
interpretation.
CONCLUSION
We hope that future research will be theoretically informed,
seeking to address research questions derived from and relevant
to psychological theory. By taking this kind of approach we
have shown that information about the prevalence of a behavior
amongst peers – in this case use of NE to improve academic
performance – might have a deterrent eﬀect via attitude to NE
and willingness to engage in NE. The approach described in this
study might be particularly useful for the designers of public
health campaigns.
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